Stuart Haslam

Stuart Haslam is a Professor in Structural Glycobiology at the Department of Life Sciences, Imperial College London. His work focuses on glycobiology, particularly the structural analysis of glycoconjugates in diverse biological systems, including bacteria and humans. He leads the Analytical Glycotechnology Core for the NIH-funded Consortium for Functional Glycomics (CFG), specializing in glycomic profiling and carbohydrate structure analysis. His research integrates glycosylation mechanisms with clinical applications, such as preterm birth risk factors, cancer biology, and vaccine development. He has affiliations with the EuroCarbDB consortium, advancing carbohydrate database infrastructure.

Education: PhD and first degree from the University of Leeds. Postdoctoral research at Imperial College London established methodologies for high-sensitivity mass spectrometry analysis of oligosaccharides, recognized by a Young Scientist Award from the International Symposium on Glycoconjugates. Awards also include contributions to understanding glycan-protein interactions in cell communication.

Research interests span glycobiology in disease contexts: infectious diseases (e.g., Helicobacter pylori), cancer glycosylation, placental biology, and immune modulation. Key projects include developing glycan-based biomarkers and engineering glycosylation pathways for therapeutic applications. He collaborates internationally on biotechnology tools like immobilized enzyme cascades for targeted glycosylation.

Grants and Funding: NIH (CFG), European Commission 6th Framework Programme (EuroCarbDB). Labs/Teams: Analytical Glycotechnology Core, Biopolymer Mass Spectrometry, Vascular Science Network.